Interlid specializes in delivering comprehensive Market Analysis services tailored for innovative healthcare ventures, including pharmaceuticals, medical devices, biotechnology, software, and digital health solutions among others, including cosmetics, functional food, agribusiness or defense related biotechnology. Our mission is to empower high growing companies by providing actionable, data-driven insights that validate market potential, identify opportunities, mitigate risks, and accelerate pathways to profitable commercialization in competitive global markets. We adopt a global and practical perspective, drawing from our deep understanding of market needs, payer dynamics, investor expectations, and the requirements of technology developers and producers. We conduct thorough, customized analyses that include some key components: (i) Feasibility analysis of the business model and technology fit within target markets; (ii) Strategic market sizing and segmentation, identifying addressable markets, growth drivers, and barriers across geographies; (iii) Competitive landscape review, benchmarking against existing solutions and emerging players; (iv) Interviews with key stakeholders, including relevant doctors, payers, decision-makers, and focus groups in reimbursement areas, when applicable; (v) Comparative analysis of protocols and clinical guidelines and reimbursement policies to inform pricing, positioning, and value demonstration; (vi) Sales forecasting and financial assessment, generating realistic projections for revenue, market penetration, and ROI; (vii) Go-to-market strategy development, including strategic recommendations for entry, positioning, and scaling in international environments; and (viii) Sales forecast based on findings of the market analysis, which may be a basis for further analysis and financial valuation. Leveraging our multidisciplinary team, comprising medical directors, market access experts, financial analysts, and commercial strategists, we deliver high-impact insights that bridge innovation with real-world market realities.
The standard hourly rate range fluctuates between €150 and €250 per hour, depending on project complexity, the required level of expertise and the involved team (senior strategists, regulatory specialists, market access experts, physicians, bioethicists, and financial analysts). Nevertheless, most clients prefer our fixed-price project structures or tailored packages, which offer predictability, and which are calculated based on the objectives and estimation of work to be done, and agreed prior to the commencement of the project. EIC beneficiaries are offered a minimum 20% discount.
The information provided in this description of Interlid Healthcare SL's Market Analysis services (including market sizing, segmentation, competitive landscape review, stakeholder interviews, clinical guideline comparisons, reimbursement analysis, go-to-market strategy, and sales forecasting) is for informational purposes only and does not constitute legal, financial, regulatory, investment, medical, or business advice. While Interlid strives to deliver accurate, high-quality, and data-driven analyses based on our expertise in healthcare, biotechnology, medical devices, pharmaceuticals, and related fields‚ drawing from global stakeholder insights, epidemiological data, reimbursement policies, and our wide experience and network in the market‚ we make no representations or warranties of any kind, express or implied, regarding the completeness, accuracy, timeliness, reliability, or suitability of the analyses, forecasts, projections, or recommendations for any particular purpose. Market analysis and sales forecasting outcomes, including market potential estimates, revenue projections, competitive positioning, reimbursement feasibility, or strategic recommendations, depend on numerous external and unpredictable factors beyond our control, such as evolving market dynamics, regulatory changes (e.g., EMA/FDA updates), payer policies, competitor actions, economic conditions, technological shifts, clinical data developments, adoption rates, and client-specific execution. Forward-looking statements, including forecasts and scenarios, are inherently uncertain and subject to risks that may cause actual results to differ materially. Interlid's services are tailored to innovative ventures, including EIC-funded companies, but past performance, client successes, or historical data do not guarantee future results or outcomes. We strongly recommend consulting qualified independent professionals‚ such as legal counsel, financial advisors, regulatory experts, investment professionals, and healthcare specialists‚ for decisions involving investments, market entry, commercialization strategies, funding rounds, mergers and acquisitions, or business planning. Interlid assumes no liability for any actions, decisions, losses, damages, or consequences (direct, indirect, incidental, consequential, or otherwise) taken or incurred based on our assessments, reports, forecasts, or services. Users of our services agree to indemnify Interlid against any claims, demands, or liabilities arising from such use.
Business Planning
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project webiste.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.